Regenerative Medical Products Regulation
Specialized regulatory pathway for regenerative medicine products with separate approval lists and review reports.
🔖 Status: in-development
This reform is part of the PMDA's ongoing programme to modernise and strengthen the Japan medical device regulatory framework. Monitor the official source for updates on timelines, consultation opportunities, and implementation guidance. Where relevant, begin assessing potential impacts on your existing registrations, technical documentation, and compliance timelines so your organisation is prepared when the reform takes effect.
View official source ↗